Lan Li
Impact in
-
- Traditional Chinese Medicine Analysis
-
- Cardiac Fibrosis and Remodeling
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
Papers in
-
- Advanced biosensing and bioanalysis techniques 2
- Ubiquitin and proteasome pathways 1
-
- Cardiac Fibrosis and Remodeling 3
- Co-authors
- Guanwei Fan (4 shared papers)Zhihao Liu (4 shared papers)Jingyu Ni (8 shared papers)Rui Guo (2 shared papers)Jing Su (2 shared papers)Sheng Li (1 shared paper)Guanwei Fan (5 shared papers)Xiumei Gao (4 shared papers)
- Journals
- Advanced Science (2 papers)Heart Failure Reviews (2 papers)Frontiers in Pharmacology (2 papers)Bioconjugate Chemistry (1 paper)Drug Delivery (1 paper)
- Partner nations
- ChinaUnited StatesMalaysia
In The Last Decade
Lan Li
24 papers receiving 973 citations
Lan Li's Hit Papers
Peers
Comparison fields: 5 of 95
- Complementary and alternative medicine 147
- Cardiology and Cardiovascular Medicine 171
- Geriatrics and Gerontology 21
- Pharmacology 56
- Neurology 47
Countries citing papers authored by Lan Li
This map shows the geographic impact of Lan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Li more than expected).
Fields of papers citing papers by Lan Li
This network shows the impact of papers produced by Lan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Li. The network helps show where Lan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Lan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | <p>Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases</p> Hit paper breakdown → | 2020 | 224 |
| 2 | 2019 | 103 | |
| 3 | 2022 | 89 | |
| 4 | 2019 | 76 | |
| 5 | 2023 | 70 | |
| 6 | 2019 | 68 | |
| 7 | 2023 | 66 | |
| 8 | 2017 | 60 | |
| 9 | 2020 | 56 | |
| 10 | 2019 | 53 | |
| 11 | 2021 | 33 | |
| 12 | 2020 | 19 | |
| 13 | 2021 | 14 | |
| 14 | 2024 | 9 | |
| 15 | 2022 | 8 | |
| 16 | 2024 | 7 | |
| 17 | 2025 | 6 | |
| 18 | 2016 | 5 | |
| 19 | 2024 | 5 | |
| 20 | 2022 | 5 |
About Lan Li
Lan Li is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Complementary and alternative medicine, Surgery and Pharmacology, having authored 26 papers that have together received 985 indexed citations. Recurring topics across this work include Traditional Chinese Medicine Analysis (3 papers), Autophagy in Disease and Therapy (3 papers), Cardiac Fibrosis and Remodeling (3 papers), Advanced Nanomaterials in Catalysis (2 papers), Tissue Engineering and Regenerative Medicine (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Alzheimer's disease research and treatments (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Complementary and alternative medicine (147 citations), Cardiology and Cardiovascular Medicine (171 citations), Geriatrics and Gerontology (21 citations), Pharmacology (56 citations) and Neurology (47 citations). Lan Li has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Guanwei Fan, Zhihao Liu, Jingyu Ni, Rui Guo, Jing Su, Sheng Li, Guanwei Fan, Xiumei Gao, Jingyuan Mao and Yan Zhu. Their work appears in journals such as Advanced Science, Heart Failure Reviews, Frontiers in Pharmacology, Bioconjugate Chemistry and Drug Delivery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.